DR. RAFFERTY & PARTNERS
BALLYCLARE GROUP PRACTICE, BALLYCLARE GROUP PRACTICE, BALLYCLARE HEALTH CENTRE, GEORGE AVENUE, BALLYCLARE
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 171 | 207 | 82.6% | |
| CKD 4 | 2008 | 220 | 271 | 81.2% | |
| CKD 5 | 2009 | 135 | 161 | 83.9% | |
| CKD 5 | 2010 | 34 | 40 | 85.0% | |
| CKD 5 | 2011 | 32 | 35 | 91.4% | |
| CKD 5 | 2012 | 30 | 34 | 88.2% | |
| CKD 5 | 2013 | 36 | 43 | 83.7% | |
| CKD003NI | 2014 | 36 | 41 | 87.8% |
